Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Research article

Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS)

Authors: Tomoyuki Hayashi, Yvan J.-F. Hutin, Marc Bulterys, Arshad Altaf, Benedetta Allegranzi

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Reuse of injection devices to give healthcare injections decreased from 39.8 to 5.5% between 2000 and 2010, but trends since 2011 have not been described. We reviewed results of Demographic and Health Surveys (DHS) to describe injection practices worldwide from 2011 to 2015.

Methods

We searched the DHS Internet site for data published on injection practices conducted in countries from 2011 to 2015, extracted information on frequency (number of healthcare injections per person in the last 12 months) and safety (proportion of syringes and needles taken from a new, unopened package). We compared gender groups and WHO regions in terms of frequency and safety. For countries with data available, we compared injection practices 2004–2010 and 2011–2015.

Results

Since 2011, 40 of 92 countries (43%) that conducted DHS surveys reported on injection practices. On average, the frequency of injection was 1.64 per person per year (from 3.84 in WHO Eastern Mediterranean region to 1.18 in WHO African region). Among those, 96.1% of injections reportedly used new injection devices (from 90.2% in the WHO Eastern Mediterranean region to 98.8% in the WHO Western Pacific region). On average, women received more injections per year (1.85) than men (1.41). Among 16 (40%) countries with data in 2004–2010 and 2011–2015, 69% improved in terms of safety. The annual number of unsafe injections reduced in 81% of countries. In Pakistan, the number of unsafe injections was the highest and did not decrease between 2006 and 2012.

Conclusions

Injection practices have continued to improve in most countries worldwide, although the Eastern Mediterranean region in particular still faces unsafe practices that are not improving. Further efforts are needed to eliminate unsafe injection practices in health care settings, including through the use of reuse-prevention devices. Despite some limitations, DHS is an easily available method to measure progress over time.
Literature
1.
go back to reference Hutin Y, Hauri Y, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003;81:491–500.PubMedPubMedCentral Hutin Y, Hauri Y, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, et al. Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections. Bull World Health Organ. 2003;81:491–500.PubMedPubMedCentral
2.
go back to reference Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ. 2003;327:1075.CrossRef Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ. 2003;327:1075.CrossRef
4.
go back to reference Hutin YJF, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M, et al. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol. 1999;28:782–6.CrossRef Hutin YJF, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M, et al. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol. 1999;28:782–6.CrossRef
5.
go back to reference Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect. 1997;119:349–56.CrossRef Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect. 1997;119:349–56.CrossRef
6.
go back to reference Hersh BS, Popovici F, Jezek Z, Satten GA, Apetrei RC, Beldescu N, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS. 1993;7:1617–24.CrossRef Hersh BS, Popovici F, Jezek Z, Satten GA, Apetrei RC, Beldescu N, et al. Risk factors for HIV infection among abandoned Romanian children. AIDS. 1993;7:1617–24.CrossRef
7.
go back to reference Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15:7–16.CrossRef Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15:7–16.CrossRef
14.
go back to reference Hutin YJ, Bulterys M, Hirnschall GO. How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc. 2018;Suppl 2:e25050.CrossRef Hutin YJ, Bulterys M, Hirnschall GO. How far are we from viral hepatitis elimination service coverage targets? J Int AIDS Soc. 2018;Suppl 2:e25050.CrossRef
15.
18.
go back to reference Talaat M, El-Sayed N, Kandeel A, Azab MA, Afifi S, Youssef FG, et al. Sentinel surveillance for patients with acute hepatitis in Egypt, 2001-04. East Mediterr Health J. 2010;16:134–40.CrossRef Talaat M, El-Sayed N, Kandeel A, Azab MA, Afifi S, Youssef FG, et al. Sentinel surveillance for patients with acute hepatitis in Egypt, 2001-04. East Mediterr Health J. 2010;16:134–40.CrossRef
19.
go back to reference Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP. Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan. Epidemiol Infect. 2003;130:293–300.CrossRef Usman HR, Akhtar S, Rahbar MH, Hamid S, Moattar T, Luby SP. Injections in health care settings: a risk factor for acute hepatitis B virus infection in Karachi, Pakistan. Epidemiol Infect. 2003;130:293–300.CrossRef
20.
go back to reference Centers for Disease Control and Prevention (CDC). Establishment of a viral hepatitis surveillance system--Pakistan, 2009–2011. MMWR Morb Mortal Wkly Rep. 2011;60:1385–90. Centers for Disease Control and Prevention (CDC). Establishment of a viral hepatitis surveillance system--Pakistan, 2009–2011. MMWR Morb Mortal Wkly Rep. 2011;60:1385–90.
21.
go back to reference Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ. 2000;78:956–63.PubMedPubMedCentral Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ. 2000;78:956–63.PubMedPubMedCentral
22.
go back to reference Paez Jimenez A, El-Din NS, El-Hoseiny M, El-Daly M, Abdel-Hamid M, El Aidi S, et al. Community transmission of hepatitis B virus in Egypt: results from a case-control study in greater Cairo. Int J Epidemiol. 2009;38:757–65.CrossRef Paez Jimenez A, El-Din NS, El-Hoseiny M, El-Daly M, Abdel-Hamid M, El Aidi S, et al. Community transmission of hepatitis B virus in Egypt: results from a case-control study in greater Cairo. Int J Epidemiol. 2009;38:757–65.CrossRef
23.
go back to reference Paez Jimenez A, Mohamed MK, Eldin NS, Seif HA, El Aidi S, Sultan Y, et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One. 2009;4:e7193.CrossRef Paez Jimenez A, Mohamed MK, Eldin NS, Seif HA, El Aidi S, Sultan Y, et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One. 2009;4:e7193.CrossRef
24.
go back to reference Singh J, Bhatia R, Patnaik SK, Khare S, Bora D, Jain DC, et al. Community studies on hepatitis B in Rajahmundry town of Andhra Pradesh, India, 1997-8: unnecessary therapeutic injections are a major risk factor. Epidemiol Infect. 2000;125:367–75.CrossRef Singh J, Bhatia R, Patnaik SK, Khare S, Bora D, Jain DC, et al. Community studies on hepatitis B in Rajahmundry town of Andhra Pradesh, India, 1997-8: unnecessary therapeutic injections are a major risk factor. Epidemiol Infect. 2000;125:367–75.CrossRef
25.
go back to reference Narendranathan M, Philip M. Reusable needles-a major risk factor for acute virus B hepatitis. Trop Dr. 1993;23:64–6.CrossRef Narendranathan M, Philip M. Reusable needles-a major risk factor for acute virus B hepatitis. Trop Dr. 1993;23:64–6.CrossRef
27.
go back to reference The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–76.CrossRef The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161–76.CrossRef
29.
go back to reference Lim AG, Qureshi H, Mahmood H, Hamid S, Davies CF, Trickey A, et al. Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination. Int J Epidemiol. 2018;47:550–60.CrossRef Lim AG, Qureshi H, Mahmood H, Hamid S, Davies CF, Trickey A, et al. Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination. Int J Epidemiol. 2018;47:550–60.CrossRef
31.
go back to reference Dentinger C, Pasat L, Popa M, Hutin YJ, Mast EE. Injection practices in Romania: progress and challenges. Infect Control Hosp Epidemiol. 2004;25:30–5.CrossRef Dentinger C, Pasat L, Popa M, Hutin YJ, Mast EE. Injection practices in Romania: progress and challenges. Infect Control Hosp Epidemiol. 2004;25:30–5.CrossRef
32.
go back to reference Janjua NZ, Mahmood B, Imran KM. Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan? J Infect Public Health. 2014;7:345–55.CrossRef Janjua NZ, Mahmood B, Imran KM. Does knowledge about bloodborne pathogens influence the reuse of medical injection syringes among women in Pakistan? J Infect Public Health. 2014;7:345–55.CrossRef
33.
go back to reference Janjua NZ, Hamza HB, Islam M, Tirmizi SF, Siddiqui A, Jafri W, et al. Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. J Viral Hepat. 2010;17:317–26.CrossRef Janjua NZ, Hamza HB, Islam M, Tirmizi SF, Siddiqui A, Jafri W, et al. Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. J Viral Hepat. 2010;17:317–26.CrossRef
34.
go back to reference Khan UR, Janjua NZ, Akhtar S, Hatcher J. Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Tropical Med Int Health. 2008;13:754–61.CrossRef Khan UR, Janjua NZ, Akhtar S, Hatcher J. Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Tropical Med Int Health. 2008;13:754–61.CrossRef
39.
go back to reference Logez SM, Hutin YJ, Holloway K, Gray R, Hogerzeil HV. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections? J Clin Pharmacol. 2004;44:1106–13 Review.CrossRef Logez SM, Hutin YJ, Holloway K, Gray R, Hogerzeil HV. Could the WHO model list of essential medicines do more for the safe and appropriate use of injections? J Clin Pharmacol. 2004;44:1106–13 Review.CrossRef
Metadata
Title
Injection practices in 2011–2015: a review using data from the demographic and health surveys (DHS)
Authors
Tomoyuki Hayashi
Yvan J.-F. Hutin
Marc Bulterys
Arshad Altaf
Benedetta Allegranzi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-4366-9

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue